Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:GLEO

Galileo Acquisition (GLEO) Stock Price, News & Analysis

Galileo Acquisition logo

About Galileo Acquisition Stock (NYSE:GLEO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$7.24
$10.64
52-Week Range
N/A
Volume
N/A
Average Volume
115,273 shs
Market Capitalization
$3,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Galileo Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to focus on companies operating in the consumer, retail, food and beverage, fashion and luxury, specialty industrial, technology or healthcare sectors. Galileo Acquisition Corp. was incorporated in 2019 and is based in New York, New York.

Receive GLEO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Galileo Acquisition and its competitors with MarketBeat's FREE daily newsletter.

GLEO Stock News Headlines

Shapeways Holdings, Inc. (SHPWQ)
Galileo High School
2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisis
What's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot-com bust, worse than the COVID crash, and even worse than the Great Depression. What's coming, he says, could soon crash the market by 50% or more – and keep it down for 10, 20, or even 30 years.
Replay: Shapeways CEO in Fireside Chat
Join Shapeways CEO in Fireside Chat on Sept. 21 at 3PM EDT
See More Headlines

GLEO Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Galileo Acquisition investors own include Ceragon Networks (CRNT), LogicBio Therapeutics (LOGC), Avidity Biosciences (RNA), Adaptive Biotechnologies (ADPT), Precision BioSciences (DTIL), Homology Medicines (FIXX) and Gossamer Bio (GOSS).

Company Calendar

Today
4/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Miscellaneous Manufacturing Industries
Sub-Industry
N/A
Current Symbol
NYSE:GLEO
Phone
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-1,530,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.29 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$3,000.00
Optionable
Not Optionable
Beta
0.15
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NYSE:GLEO) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners